Sickle cell anemia-related brain injury in children reduced by monthly blood transfusions
8/22/2014
Regular blood transfusions prevent recurrent blockage of brain blood vessels, a serious neurological side effect that occurs in one third of children with sickle cell anemia, according to a study...
Genetics and lifestyle have a strong impact on biomarkers for inflammation and cancer
8/22/2014
In a new study published in Nature Communications, research scientists from Uppsala University present for the first time a large-scale study of the significance of genetic, clinical and lifestyle...
Indication of considerable added benefit for ruxolitinib in myelofibrosis
8/22/2014
Advantages in symptoms and survival time in comparison with "best supportive care"Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with...
Reduced-nicotine cigarettes 'do not lead to increased smoking intensity'
8/22/2014
Fears that reduced-nicotine cigarettes could lead to smokers needing more cigarettes to satisfy their cravings may well be unfounded, according to a recent study.
NSAIDs may halve breast cancer recurrence in overweight women
8/22/2014
In a new study, overweight and obese breast cancer patients exhibited a 52% lower rate of recurrence and a 28-month delay in recurrence if they were regularly taking NSAIDs.
Scientists have made it easier to predict both breast cancer relapses and responses to chemotherapy, through the identification of a unique gene.
Overactive protein in basal-like carcinoma offers target for new breast cancer therapeutics
8/22/2014
Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy.
Blood test may revolutionize brain cancer diagnosis
8/21/2014
Scientists at Virginia Tech's Virginia Bioinformatics Institute working with the Center for Cancer and Blood Disorders at Children's National Medical Center have found a new way to diagnose brain...
Blueprint for the next generation of chronic myeloid leukemia treatment
8/21/2014
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have identified and characterized mutated forms of the gene that encodes BCR-ABL, the unregulated enzyme driving the blood...
NICE clears path for patient access to Revlimid® (lenalidomide) for rare form of blood cancer
8/21/2014
Celgene is pleased to announce that the National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) on its oral blood cancer treatment REVLIMID®...